1. "2024"
Formats
  1. Journal Article (2329)
  2. Meeting Abstract (1694)
  3. Review (589)
  4. Editorial (305)
  5. Book Section (98)
  6. Correspondence (92)
  7. Guidelines (90)
  8. Research Letter (89)
  9. Miscellaneous (55)
  10. Conference Paper (33)
  11. Book Whole (3)
Groups
  1. Department of Medicine (2141)
  2. Solid Tumor Oncology Division (1382)
  3. Sloan Kettering Institute Postdocs (1038)
  4. Surgery (984)
  5. Graduate Medical Education (883)
  6. GSK Faculty (868)

More Groups

People
  1. Eileen O'Reilly (75)
  2. Saad Usmani (75)
  3. Edward Christopher Dee (70)
  4. Nadeem Abu-Rustum (70)
  5. Alice Wei (69)
  6. T Peter Kingham (68)

More People

Years
  1. 2024 (5377)
Publications
  1. Journal of Clinical Oncology (521)
  2. International Journal of Radiation Oncology, Biology, Physics (186)
  3. Blood (161)
  4. Annals of Oncology (147)
  5. Annals of Surgical Oncology (131)
  6. Laboratory Investigation (91)

More Publications

Publishers
  1. Elsevier Inc. (784)
  2. American Society of Clinical Oncology (580)
  3. Nature Publishing Group (384)
  4. Springer (357)
  5. Oxford University Press (347)
  6. Elsevier Science, Inc. (256)

More Publishers

Results (5377)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Longer-term safety and efficacy of selinexor maintenance therapy for patients with TP53WT advanced or recurrent endometrial cancer: Follow up subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
    Meeting Abstract

    Fidalgo, J. A. P.; Vergote, I.; Hamilton, E.; Giorgi, U. D.; Gorp, T. V.; Lübbe, K.; Zikan, M.; Helpman, L.; Miller, D. S.; Fariñas-Madrid, L.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Benefit from atezolizumab in patients with a poor prognostic ovarian cancer in first-line setting: IMAGYN-050 trial
    Meeting Abstract

    You, B.; Anderson, C.; Cecere, S. C.; Carrot, A.; Myers, T.; Heitz, F.; Sudarshan, S.; Selcukbiricik, F.; Aghajanian, C.; Fernebro, J.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • A phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator’s choice of therapy in patients with recurrent low-grade serous ovarian cancer: GOG-3097/ENGOT-ov81/NCRI/RAMP 301
    Meeting Abstract

    Grisham, R.; Monk, B.; Van Nieuwenhuysen, E.; Moore, K.; Fabbro, M.; O'Malley, D.; Oaknin, A.; Thaker, P.; Oza, A.; Colombo, N.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Randomized, phase II/III study of pegylated liposomal doxorubicin, bevacizumab, and atezolizumab in platinum-resistant ovarian cancer (NRG-GY009): Clinical outcomes by PD-L1 and T cell infiltration status
    Meeting Abstract

    O'Cearbhaill, R.; Zamarin, D.; Sill, M.; Duong, H.; Waggoner, S.; Grisham, R.; Backes, F.; Mannel, R.; Tanyi, J.; Powell, M.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Efficacy and safety of avutometinib ± defactinib in recurrent low grade serous ovarian cancer: Primary analysis of ENGOT-OV60/GOG-3052/RAMP 201
    Meeting Abstract

    Banerjee, S.; Aghajanian, C.; Van Nieuwenhuysen, E.; Santin, A.; Ring, K.; Colombo, N.; Thaker, P.; Prendergast, E.; Moore, K.; Chon, H. S.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Extracting phenotypes from clinical descriptions using large language models: A comparison between automated and manual approach
    Meeting Abstract

    Berardelli, S.; Gazzo, A.; De Paoli, F.; Limongelli, I.; Rizzo, E.; Magni, P.; Zucca, S.
    European Journal of Human Genetics (2024)

    Fulltext@MSK | Save
  • The spectrum of SMARCB1-deficient tumors extends to T-cell lymphomas enriched in children and young adults
    Meeting Abstract

    Fischer, A.; Moreno, N.; Interlandi, M.; Albert, T. K.; Marmann, J.; Glaser, S.; Verma, A.; Patil, P.; Balbach, S. T.; Wagener, R.; more...
    European Journal of Human Genetics (2024)

    Fulltext@MSK | Save
  • Deciphering the gene expression signature of high-grade B-cell lymphomas with 11q aberrations
    Meeting Abstract

    Chteinberg, E.; Di Stefano, G.; Löffler-Wirth, H.; Staiger, A. M.; Hillebrecht, S.; Wagener, R.; Bens, S.; Oehl-Huber, K.; Dahlum, S.; Abramov, D.; more...
    European Journal of Human Genetics (2024)

    Fulltext@MSK | Save
  • Characterising the contribution of rare protein-coding variants to prostate cancer risk and severity in 36,866 cases
    Meeting Abstract

    Mitchell, J.; Camacho, N.; Shea, P. R.; Stopsack, K.; Joseph, V.; Burren, O.; Penney, K.; Berchuck, J.; Wang, Q. L.; Goldstein, D.; more...
    European Journal of Human Genetics (2024)

    Fulltext@MSK | Save
  • Cerebral hemodynamics improve in adults with sickle cell disease after gene therapy
    Meeting Abstract

    Sharma, A.; Hankins, J. S.; Boelens, J. J.; Cancio, M.; Peddinti, R.; Rispoli, L.; Sloan, S.; Costa, S. D.; Peled, S.; Wiethoff, A.; more...
    Blood (2024)

    Fulltext@MSK | Save